These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6170181)

  • 1. [Measurement of urinary flow in general practice. Efficacy of beta-sitosterine].
    Klingeberg J
    ZFA (Stuttgart); 1981 Oct; 57(28):1634-7. PubMed ID: 6170181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urination disorders caused by prostatic hyperplasia. Effect of Bazoton, Harzol and Prosta-capsules].
    Hallwachs O
    MMW Munch Med Wochenschr; 1981 Oct; 123(44):1675-6. PubMed ID: 6171728
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
    Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
    Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conservative therapy of prostatic hyperplasia with urinary retention].
    Djulepa J
    Med Welt; 1983 Dec; 34(48):1377-9. PubMed ID: 6197601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of prostatic nycturia with standardized extractum radix urticae].
    Stahl HP
    ZFA (Stuttgart); 1984 Jan; 60(3):128-32. PubMed ID: 6201019
    [No Abstract]   [Full Text] [Related]  

  • 7. Serenoa repens and benign prostatic hyperplasia: no more effective than placebo.
    Prescrire Int; 2010 Aug; 19(108):181-2. PubMed ID: 20941857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urodynamic study in patients with prostatic hyperplasia].
    Shishido K; Yamaguchi O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():346-51. PubMed ID: 12599598
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical treatment of fibroadenomatous hypertrophy of the prostate with a new plant substance].
    Maver A
    Minerva Med; 1972 May; 63(37):2126-36. PubMed ID: 4113157
    [No Abstract]   [Full Text] [Related]  

  • 10. The urodynamic assessment of benign prostatic hyperplasia obstruction.
    Artibani W
    J Urol (Paris); 1995; 101(1):42-4. PubMed ID: 7545728
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study].
    Barlet A; Albrecht J; Aubert A; Fischer M; Grof F; Grothuesmann HG; Masson JC; Mazeman E; Mermon R; Reichelt H
    Wien Klin Wochenschr; 1990 Nov; 102(22):667-73. PubMed ID: 1702916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma].
    Dufour B; Choquenet C; Revol M; Faure G; Jorest R
    Ann Urol (Paris); 1984 May; 18(3):193-5. PubMed ID: 6084978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China. R. Shi, Q. Xie, X. Gang, J. Lun, L. Cheng, A. Pantuck and J. Rao. J Urol 2008; 179: 610-615.
    Ozdemir AT; Serefoglu EC; Balbay MD
    J Urol; 2008 Sep; 180(3):1188; author reply 1188. PubMed ID: 18639898
    [No Abstract]   [Full Text] [Related]  

  • 14. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of a combined Sabal-urtica preparation in the symptomatic treatment of benign prostatic hyperplasia. Results of a placebo-controlled double-blind study].
    Popa G; Hägele-Kaddour H; Walther C
    MMW Fortschr Med; 2005 Oct; 147 Suppl 3():103-8. PubMed ID: 16261945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, controlled, multicenter study of naftopidil for treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: 75 mg once daily in the evening compared to 25 mg thrice daily.
    Tsuritani S; Nozaki T; Okumura A; Kimura H; Kazama T
    Urol Int; 2010; 85(1):80-7. PubMed ID: 20516676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study].
    Dörner G; Fritsche C
    ZFA (Stuttgart); 1982 Jan; 58(3):167-9. PubMed ID: 6176081
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term efficacy of naftopidil for treatment of lower urinary tract symptoms with benign prostatic hyperplasia].
    Akasaka T; Funaki H; Hirano S; Ohinata M; Fujishima M; Kudou T; Suzuki A; Iinuma M
    Hinyokika Kiyo; 2003 Apr; 49(4):189-93. PubMed ID: 12784711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews.
    Kim TH; Lim HJ; Kim MS; Lee MS
    Maturitas; 2012 Nov; 73(3):180-5. PubMed ID: 22883375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on tolterodine for men with benign prostatic hyperplasia and lower urinary tract symptoms.
    O'Leary MP
    J Urol; 2008 May; 179(5 Suppl):S86. PubMed ID: 18405764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.